314 related articles for article (PubMed ID: 9473218)
21. Role of Leu99 of thrombin in determining the P2 specificity of serpins.
Rezaie AR
Biochemistry; 1997 Jun; 36(24):7437-46. PubMed ID: 9200692
[TBL] [Abstract][Full Text] [Related]
22. Interference of blood-coagulation vitamin K-dependent proteins in the activation of human protein C. Involvement of the 4-carboxyglutamic acid domain in two distinct interactions with the thrombin-thrombomodulin complex and with phospholipids.
Freyssinet JM; Beretz A; Klein-Soyer C; Gauchy J; Schuhler S; Cazenave JP
Biochem J; 1988 Dec; 256(2):501-7. PubMed ID: 2851994
[TBL] [Abstract][Full Text] [Related]
23. A direct thrombin inhibitor suppresses protein C activation and factor Va degradation in human plasma: Possible mechanisms of paradoxical enhancement of thrombin generation.
Kamisato C; Furugohri T; Morishima Y
Thromb Res; 2016 May; 141():77-83. PubMed ID: 26974491
[TBL] [Abstract][Full Text] [Related]
24. Antithrombin-independent thrombin inhibitors, but not direct factor Xa inhibitors, enhance thrombin generation in plasma through inhibition of thrombin-thrombomodulin-protein C system.
Furugohri T; Sugiyama N; Morishima Y; Shibano T
Thromb Haemost; 2011 Dec; 106(6):1076-83. PubMed ID: 22012070
[TBL] [Abstract][Full Text] [Related]
25. Direct thrombin inhibitors, but not the direct factor Xa inhibitor rivaroxaban, increase tissue factor-induced hypercoagulability in vitro and in vivo.
Perzborn E; Heitmeier S; Buetehorn U; Laux V
J Thromb Haemost; 2014 Jul; 12(7):1054-65. PubMed ID: 24766850
[TBL] [Abstract][Full Text] [Related]
26. Purification and characterization of plasma protein C inhibitor.
España F; Berrettini M; Griffin JH
Thromb Res; 1989 Aug; 55(3):369-84. PubMed ID: 2551064
[TBL] [Abstract][Full Text] [Related]
27. The impact of the endothelial protein C receptor on thrombin generation and clot lysis.
Pepler L; Wu C; Dwivedi DJ; Wu C; Kim PY; Liaw PC
Thromb Res; 2017 Apr; 152():30-37. PubMed ID: 28219843
[TBL] [Abstract][Full Text] [Related]
28. Thrombomodulin as a model of molecular mechanisms that modulate protease specificity and function at the vessel surface.
Esmon CT
FASEB J; 1995 Jul; 9(10):946-55. PubMed ID: 7615164
[TBL] [Abstract][Full Text] [Related]
29. Detection of procoagulant imbalance. Modified endogenous thrombin potential with results expressed as ratio of values with-to-without thrombomodulin.
Tripodi A
Thromb Haemost; 2017 May; 117(5):830-836. PubMed ID: 28229158
[TBL] [Abstract][Full Text] [Related]
30. C1-esterase inhibitor enhances thrombin generation and spatial fibrin clot propagation in the presence of thrombomodulin.
Tarandovskiy ID; Buehler PW; Ataullakhanov FI; Karnaukhova E
Thromb Res; 2019 Apr; 176():54-60. PubMed ID: 30784776
[TBL] [Abstract][Full Text] [Related]
31. The effect of aprotinin on activated protein C-mediated downregulation of endogenous thrombin generation.
Tanaka KA; Szlam F; Levy JH
Br J Haematol; 2006 Jul; 134(1):77-82. PubMed ID: 16803571
[TBL] [Abstract][Full Text] [Related]
32. Protease nexin-1 interacts with thrombomodulin and modulates its anticoagulant effect.
Bouton MC; Venisse L; Richard B; Pouzet C; Arocas V; Jandrot-Perrus M
Circ Res; 2007 Apr; 100(8):1174-81. PubMed ID: 17379830
[TBL] [Abstract][Full Text] [Related]
33. High-mobility group box 1 protein promotes development of microvascular thrombosis in rats.
Ito T; Kawahara K; Nakamura T; Yamada S; Nakamura T; Abeyama K; Hashiguchi T; Maruyama I
J Thromb Haemost; 2007 Jan; 5(1):109-16. PubMed ID: 17239166
[TBL] [Abstract][Full Text] [Related]
34. Paradoxical enhancement of the intrinsic pathway-induced thrombin generation in human plasma by melagatran, a direct thrombin inhibitor, but not edoxaban, a direct factor Xa inhibitor, or heparin.
Furugohri T; Morishima Y
Thromb Res; 2015 Sep; 136(3):658-62. PubMed ID: 26188924
[TBL] [Abstract][Full Text] [Related]
35. Modulation of protein C inhibitor activity.
Neese LL; Pratt CW; Church FC
Blood Coagul Fibrinolysis; 1994 Oct; 5(5):737-46. PubMed ID: 7532447
[TBL] [Abstract][Full Text] [Related]
36. Feedback activation of factor XI by thrombin in plasma results in additional formation of thrombin that protects fibrin clots from fibrinolysis.
von dem Borne PA; Meijers JC; Bouma BN
Blood; 1995 Oct; 86(8):3035-42. PubMed ID: 7579397
[TBL] [Abstract][Full Text] [Related]
37. Extracellular histones increase plasma thrombin generation by impairing thrombomodulin-dependent protein C activation.
Ammollo CT; Semeraro F; Xu J; Esmon NL; Esmon CT
J Thromb Haemost; 2011 Sep; 9(9):1795-803. PubMed ID: 21711444
[TBL] [Abstract][Full Text] [Related]
38. Increased tissue factor-initiated prothrombin activation as a result of the Arg506 --> Gln mutation in factor VLEIDEN.
van 't Veer C; Kalafatis M; Bertina RM; Simioni P; Mann KG
J Biol Chem; 1997 Aug; 272(33):20721-9. PubMed ID: 9252393
[TBL] [Abstract][Full Text] [Related]
39. Pharmacological Differentiation of Thrombomodulin Alfa and Activated Protein C on Coagulation and Fibrinolysis In Vitro.
Tanaka K; Tawara S; Tsuruta K; Hoppensteadt D; Fareed J
Clin Appl Thromb Hemost; 2018 Sep; 24(6):859-866. PubMed ID: 29683037
[TBL] [Abstract][Full Text] [Related]
40. Coagulation-dependent inhibition of fibrinolysis: role of carboxypeptidase-U and the premature lysis of clots from hemophilic plasma.
Broze GJ; Higuchi DA
Blood; 1996 Nov; 88(10):3815-23. PubMed ID: 8916945
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
